Hepatitis C Treatment Center

The Hepatitis C Treatment Centers, led by Dr. Bennet D. Cecil III, is dedicated to addressing the significant Hepatitis C (HCV) epidemic in Kentucky, where only a small percentage of infected individuals have received effective treatment in recent years. Established in 1998, the center has successfully cured thousands of patients and is recognized as the largest HCV treatment facility in the United States. With a focus on innovative oral medications like Mavyret and Epclusa, which boast cure rates of 98%, the clinic provides both onsite and telemedicine services across multiple locations in Kentucky. Additionally, HCTC collaborates with substance abuse specialists to enhance patient care and support those affected by HCV. Generated from the website

The Hepatitis C Treatment Centers, led by Dr. Bennet Cecil, are dedicated to addressing the critical issue of Hepatitis C (HCV) in Kentucky, a state significantly impacted by an injection drug epidemic. Since opening in 1998, they have become the largest HCV treatment center in the USA, successfully curing thousands of patients through both on-site and telemedicine services. With a commitment to improving patient outcomes, the center offers advanced oral medications like Mavyret and Epclusa, which boast cure rates of 98% over eight or twelve weeks. The organization also actively collaborates with substance abuse specialists to provide comprehensive care for those affected by HCV. Generated from the website

The Hepatitis C Treatment Centers, founded by Dr. Bennet Cecil in 1998, is the largest HCV treatment center in the USA, located in Louisville, KY. With a focus on combating the high rates of Hepatitis C in Kentucky, the center has successfully cured thousands of patients using effective oral medications like Mavyret and Epclusa. In addition to on-site treatments, the center offers telemedicine services and collaborates with substance abuse specialists to provide comprehensive care. The organization is dedicated to improving patient outcomes and addressing the ongoing challenges posed by the state's injection drug epidemic. Generated from the website